A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease.
Article in Journal of Virology (April 2024)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Article in Journal of Virology (April 2024)
Article in Cell Reports (January 2024)
Preprint in bioRxiv (June 2023)